One of the key numbers that we commonly base our discussions and posts on is the p number (statistical significance) used to determine the success of our trials.
I was googling if a p value of less than or equal to 0.05 is sacrosanct in the statistical
The question I'm interested in is this -
Has the FDA ever approved a drug/therapy that has a p value higher than 0.05 ?
Here's a relevant debate -QuestionAsked 19th Feb, 2014What prevents you from using a p-value other than 0.05 as your statistical significance cut-off?
https://www.researchgate.net/post/What_prevents_you_from_using_a_p-value_other_than_005_as_your_statistical_significance_cut-off
Cell Therapy News/Articles, page-10102
-
- There are more pages in this discussion • 8,305 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
0.040(3.16%) |
Mkt cap ! $1.490B | |||
| Open | High | Low | Value | Volume |
| $1.28 | $1.32 | $1.26 | $3.433M | 2.652M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39558 | $1.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 21776 | 3 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |